影响疫苗研发与供应未来的趋势：人口统计学、监管科学、反疫苗运动及疫苗组学的作用
Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics.
作者信息
Poland Gregory A, Jacobson Robert M, Ovsyannikova Inna G
机构信息
Mayo Vaccine Research Group, Mayo Clinic, Rochester, MN 55905, USA.
出版信息
Vaccine. 2009 May 26;27(25-26):3240-4. doi: 10.1016/j.vaccine.2009.01.069. Epub 2009 Feb 5.
Abstract
Important scientific, cultural, temporal, and secular issues impact the development of, and delivery of vaccines. In this paper we discuss the impact of demographics, regulatory science, the anti-vaccine movement, and finally the impact of the new biology and individualized medicine, which we call vaccinomics, on vaccine development and delivery. A description of the issues and how they have, are, or should be impacting vaccinology is provided, and hopefully will result in increased attention and discussion among vaccinologists. These issues have been under-valued, under-discussed, and in some cases, ignored. We hope that discussion of these issues will result in changes in how we develop, and how we communicate those developments, to the public.
摘要
重要的科学、文化、时代和世俗问题会影响疫苗的研发与供应。在本文中，我们将探讨人口统计学、监管科学、反疫苗运动的影响，以及最后新生物学和个性化医学（我们称之为疫苗组学）对疫苗研发与供应的影响。文中描述了这些问题以及它们已经、正在或应该如何影响疫苗学，希望能引起疫苗学家更多的关注和讨论。这些问题一直未得到充分重视、讨论不足，在某些情况下甚至被忽视。我们希望对这些问题的讨论能够改变我们研发疫苗的方式，以及我们向公众传达这些进展的方式。
相似文献
1
Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics.
Vaccine. 2009 May 26;27(25-26):3240-4. doi: 10.1016/j.vaccine.2009.01.069. Epub 2009 Feb 5.
2
Quantum vaccinomics platforms to advance in vaccinology.
Front Immunol. 2023 Jun 15;14:1172734. doi: 10.3389/fimmu.2023.1172734. eCollection 2023.
3
Vaccinomics, predictive vaccinology and the future of vaccine development.
Future Microbiol. 2010 Dec;5(12):1757-60. doi: 10.2217/fmb.10.146.
4
Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?
PLoS Pathog. 2011 Dec;7(12):e1002344. doi: 10.1371/journal.ppat.1002344. Epub 2011 Dec 29.
5
Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century.
Semin Immunol. 2013 Apr;25(2):89-103. doi: 10.1016/j.smim.2013.04.007. Epub 2013 Jun 5.
6
Diagnostic testing for vaccinomics: is the regulatory approval framework adequate? A comparison of Canada, the United States, and Europe.
OMICS. 2011 Sep;15(9):597-605. doi: 10.1089/omi.2010.0135. Epub 2011 Jul 5.
7
Vaccinomics: a future avenue for vaccine development against emerging pathogens.
Expert Rev Vaccines. 2021 Dec;20(12):1561-1569. doi: 10.1080/14760584.2021.1987222. Epub 2021 Oct 13.
8
Information technologies for vaccine research.
Expert Rev Vaccines. 2005 Jun;4(3):407-17. doi: 10.1586/14760584.4.3.407.
9
Vaccine process technology.
Biotechnol Bioeng. 2012 Jun;109(6):1443-60. doi: 10.1002/bit.24493. Epub 2012 Mar 30.
10
Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections.
OMICS. 2011 Sep;15(9):625-36. doi: 10.1089/omi.2011.0032. Epub 2011 Jul 6.
引用本文的文献
1
Age-related changes in the immune system and challenges for the development of age-specific vaccines.
Ann Med. 2025 Dec;57(1):2477300. doi: 10.1080/07853890.2025.2477300. Epub 2025 Mar 20.
2
Effectiveness of chatbots on COVID vaccine confidence and acceptance in Thailand, Hong Kong, and Singapore.
NPJ Digit Med. 2023 May 25;6(1):96. doi: 10.1038/s41746-023-00843-6.
3
Vaccinomics: A scoping review.
Vaccine. 2023 Mar 31;41(14):2357-2367. doi: 10.1016/j.vaccine.2023.02.009. Epub 2023 Feb 18.
4
Prospects of malaria vaccination in Nigeria: Anticipated challenges and lessons from previous vaccination campaigns.
Ann Med Surg (Lond). 2022 Aug 17;81:104385. doi: 10.1016/j.amsu.2022.104385. eCollection 2022 Sep.
5
Impact of vaccine hesitancy on secondary COVID-19 outbreaks in the US: an age-structured SIR model.
BMC Infect Dis. 2022 Jun 1;22(1):511. doi: 10.1186/s12879-022-07486-0.
6
Vaccine Hesitancy in Saudi Arabia: A Cross-Sectional Study.
Trop Med Infect Dis. 2022 Apr 12;7(4):60. doi: 10.3390/tropicalmed7040060.
7
General vaccination knowledge influences nurses' and midwives' COVID-19 vaccination intention in Cyprus: a nationwide cross-sectional study.
Hum Vaccin Immunother. 2022 Dec 31;18(1):1-9. doi: 10.1080/21645515.2021.2016008. Epub 2022 Jan 21.
8
Sociodemographic and Behavioral Predictors of COVID-19 Vaccine Hesitancy in Pakistan.
J Multidiscip Healthc. 2021 Oct 9;14:2847-2856. doi: 10.2147/JMDH.S325529. eCollection 2021.
9
Vaccination as a preventative measure contributing to immune fitness.
NPJ Vaccines. 2021 Jul 27;6(1):93. doi: 10.1038/s41541-021-00354-z.
10
Vaccine Hesitancy and Rejection of a Vaccine for the Novel Coronavirus in the United States.
Front Immunol. 2021 Jun 14;12:558270. doi: 10.3389/fimmu.2021.558270. eCollection 2021.
本文引用的文献
1
Immunogenetics of seasonal influenza vaccine response.
Vaccine. 2008 Sep 12;26 Suppl 4(Suppl 4):D35-40. doi: 10.1016/j.vaccine.2008.07.065.
2
Personalized vaccines: the emerging field of vaccinomics.
Expert Opin Biol Ther. 2008 Nov;8(11):1659-67. doi: 10.1517/14712598.8.11.1659.
3
Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial.
JAMA. 2008 Oct 1;300(13):1532-43. doi: 10.1001/jama.300.13.1532.
4
Vaccine immunogenetics: bedside to bench to population.
Vaccine. 2008 Nov 18;26(49):6183-8. doi: 10.1016/j.vaccine.2008.06.057. Epub 2008 Jul 1.
5
Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine.
Pediatrics. 2008 May;121(5):e1091-9. doi: 10.1542/peds.2007-1575.
6
Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results.
Vaccine. 2008 Mar 25;26(14):1731-6. doi: 10.1016/j.vaccine.2008.01.017. Epub 2008 Feb 4.
7
Vaccines: countering anthrax: vaccines and immunoglobulins.
Clin Infect Dis. 2008 Jan 1;46(1):129-36. doi: 10.1086/523578.
8
Pharmacology, vaccinomics, and the second golden age of vaccinology.
Clin Pharmacol Ther. 2007 Dec;82(6):623-6. doi: 10.1038/sj.clpt.6100379.
9
Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics.
Clin Pharmacol Ther. 2007 Dec;82(6):653-64. doi: 10.1038/sj.clpt.6100415. Epub 2007 Oct 31.
10
Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors.
J Allergy Clin Immunol. 2007 Sep;120(3):666-72. doi: 10.1016/j.jaci.2007.04.036. Epub 2007 Jun 8.
Zotero 插件